Product NDC: | 65649-311 |
Proprietary Name: | DIURIL |
Non Proprietary Name: | CHLOROTHIAZIDE |
Active Ingredient(s): | 250 mg/5mL & nbsp; CHLOROTHIAZIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65649-311 |
Labeler Name: | Salix Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011870 |
Marketing Category: | NDA |
Start Marketing Date: | 19620215 |
Package NDC: | 65649-311-12 |
Package Description: | 237 mL in 1 BOTTLE (65649-311-12) |
NDC Code | 65649-311-12 |
Proprietary Name | DIURIL |
Package Description | 237 mL in 1 BOTTLE (65649-311-12) |
Product NDC | 65649-311 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CHLOROTHIAZIDE |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 19620215 |
Marketing Category Name | NDA |
Labeler Name | Salix Pharmaceuticals, Inc. |
Substance Name | CHLOROTHIAZIDE |
Strength Number | 250 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |